259 Results for "

anti-tumo

" in MedChemExpress (MCE) Product Catalog:
Products (259)

259 Results for "anti-tumo" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P7306
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFSF10; APO2L; TNF Superfamily Member 10; tumor Necrosis Factor (Ligand) Family, Member 10; Apo-2L; tumor Necrosis Factor Ligand Superfamily Member; TRAIL; TNF-Related Apoptosis Inducing Ligand TRAIL; CD253; tumor Necrosis Factor Superfamily Member 10; TANCR; TNF-Related Apoptosis-Inducing Ligand; TL2; tumor Necrosis Factor Ligand 6A; Chemokine tumor Necrosis Factor Ligand Superfamily Member 10; CD253 antigen; tumor Necrosis Factor (Ligand) Superfamily, Member 10; Protein TRAIL; tumor Necrosis Factor Ligand Superfamily Member 10; TNLG6A; Apo-2 Ligand
Species:  
Human
Source:  
E. coli
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P78070
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TNFRSF17; TNFRSF13A; Prev. BCMA; tumor Necrosis Factor Receptor Superfamily, Member 17; BCM; B Cell Maturation antigen; tumor Necrosis Factor Receptor Superfamily Member 17; B-Cell Maturation Factor; B-Cell Maturation Protein; CD269 antigen; TNF Receptor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-116447
CAS No.: 1611446-66-2
Purity:  ≥99.0%
Research Areas:  

Cancer

Antitumor agent-159 (Compound 13b) targets the mitochondria and downregulates cardiolipin levels. Antitumor agent-159 inhibits the proliferation of cancer cell MDA-MB-231, arrests the cell cycle at sub-G1 phase, and induces apoptosis in MDA-MB-231. Antitumor agent-159 exhibits antitumor efficacy in MDA-MB-231 xenograft mouse models .
loading...
    loading...
Cat. No.: HY-149829
CAS No.: 2654024-16-3
Target:  

Apoptosis Autophagy

Research Areas:  

Cancer

Antitumor agent-97 (compound 42) is an anticancer agent. Antitumor agent-97 can effectively inhibit the proliferation and autophagy of MGC 803 cells, and induce apoptosis. Antitumor agent-97 also enhances ROS accumulation in MGC 803 cells. Antitumor agent-97 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-150696
CAS No.: 2676942-92-8
Target:  

Apoptosis Caspase PARP

Research Areas:  

Cancer

Antitumor agent-72 (compound 6w) is a potent anticancer agent. Antitumor agent-72 has anticancer activity and induces apoptosis through activation of caspase-3 and cleavage of PARP. Antitumor agent-72 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-151618
CAS No.: 2750233-50-0
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-79 shows good antiproliferative activities against hepatocellular carcinoma and breast cancer cells with IC50 values of 0.7-7.9 μM. Antitumor agent-79 induces cancer cells apoptosis and shows in vivo antitumor effects. Antitumor agent-79 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-151620
CAS No.: 2758520-84-0
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-80 (compound 11) is an orally active and potent antitumor agent. Antitumor agent-80 induces apoptosis in tumor cells .
loading...
    loading...
Cat. No.: HY-15961
CAS No.: 420126-30-3
Target:  

Drug Intermediate

Research Areas:  

Cancer

Antitumor agent-3 is an antitumor agent containing an imidazopyridine structure.
loading...
    loading...
Cat. No.: HY-144394
CAS No.: 2581082-74-6
Target:  

Apoptosis c-Met/HGFR

Research Areas:  

Cancer

Antitumor agent-45 (Compound 21) could induce and stimulate A549 cells apoptosis in G0/G1 and G2/M phase. Antitumor agent-45 (Compound 21) inhibits c-Met expression to regulate the growth of tumor cells .
loading...
    loading...
Cat. No.: HY-151429
CAS No.: 2870703-21-0
Research Areas:  

Cancer

Antitumor agent-77 is an antitumor agent, inhibits cancer cells growth and migration. Antitumor agent-77 triggers ferroptosis by inhibiting GPx-4 and elevating COX2. Antitumor agent-77 also activates intrinsic apoptotic pathway (Bax-Bcl-2-caspase-3) and hinders Epithelial-mesenchymal transition (EMT) process of cancer cells .
loading...
    loading...
Cat. No.: HY-152538
Target:  

G-quadruplex

Research Areas:  

Cancer

Antitumor agent-85 is a G-quadruplex (G4)-ligand with the ability to stabilize different G4-DNA structures. Antitumor agent-85 has highly effective anti-tumor properties .
loading...
    loading...
Cat. No.: HY-107470
CAS No.: 1256037-58-7
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology Cancer

Antitumor agent-21 is an aryl-quinolin derivative, with potential anticancer, anti-inflammatory, anti-proliferative, anti-hormonal effects and inhibition of vasculogenic mimicry .
loading...
    loading...
Cat. No.: HY-115948
CAS No.: 2917547-18-1
Target:  

Others

Research Areas:  

Cancer

Antitumor agent-46 (Compound 2h) is an anti-tumor agent. Antitumor agent-46 demonstrates markedly higher antiproliferative activity on MCF-7 cells with an IC50 value of 2.08 µM .
loading...
    loading...
Cat. No.: HY-115949
CAS No.: 2917547-24-9
Target:  

HSP

Research Areas:  

Cancer

Antitumor agent-47 (Compound 3e) is a silibinin derivative with an antitumor activity. Antitumor agent-47 shows cytotoxic activity against NCI-H1299 and HT29 cells with IC50 values of 8.07 µM and 6.27 µM, respectively .
loading...
    loading...
Cat. No.: HY-115950
CAS No.: 2917547-29-4
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-48 (Compound 4a) is a 2,3-dehydrosilybin derivative with an antitumor activity. Antitumor agent-48 shows cytotoxic activity against MCF-7, NCI-H1299, HepG2 and HT29 cells with IC50 values of 8.06 µM, 13.1 µM, 16.51 µM and 12.44 µM, respectively .
loading...
    loading...
Cat. No.: HY-115995
CAS No.: 2891985-53-6
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-50 (compound 1a), a thiazolidinone, is a potent antitumor agent. Antitumor agent-50 has the potential for osteosarcoma (OS) research .
loading...
    loading...
Cat. No.: HY-115996
CAS No.: 3035774-65-0
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-51 possesses potent and selective inhibitory for osteosarcoma cell growth and migration with IC50 of 21.9 nM in MNNG/HOS cells. Antitumor agent-51 has a considerable bioavailability and a low toxicity .
loading...
    loading...
Cat. No.: HY-128776
CAS No.: 2379727-90-7
Target:  

TNF Receptor

Research Areas:  

Cancer

Antitumor agent-19 is an antitumor agent that targets tumor-associated macrophages (TAMs) and can be used as a potent TAMs modulator. Antitumor agent-19 can increase TNF-alpha levels in tumor cells with EC50 values???of 17.18 μM and 18.87 μM in RAW 264.7 cells and BMDM cells, respectively .
loading...
    loading...
Cat. No.: HY-128934
CAS No.: 1351163-57-9
Target:  

Others

Research Areas:  

Inflammation/Immunology Cancer

Antitumor agent-2 is sourced from patent CN102250203, compound 6a-r, has antitumor action and anti-inflammatory action .
loading...
    loading...
Cat. No.: HY-136342
CAS No.: 2355185-12-3
Target:  

Others

Research Areas:  

Cancer

Antitumor agent-23 is a potent anti-cancer agent with GI50s of 38, 48, 5, 27, 80, and 28 nM for lymphoma cell line GRANTA-519, KARPAS-422, KARPAS-299, RAMOS, DAUDI, and RAJI, respectively. Antitumoral activity .
loading...
    loading...